DE3688075D1 - Transdermales verabreichungssystem. - Google Patents

Transdermales verabreichungssystem.

Info

Publication number
DE3688075D1
DE3688075D1 DE8787900446T DE3688075T DE3688075D1 DE 3688075 D1 DE3688075 D1 DE 3688075D1 DE 8787900446 T DE8787900446 T DE 8787900446T DE 3688075 T DE3688075 T DE 3688075T DE 3688075 D1 DE3688075 D1 DE 3688075D1
Authority
DE
Germany
Prior art keywords
transdermal administration
administration system
weight
carrier
oleic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8787900446T
Other languages
English (en)
Other versions
DE3688075T2 (de
Inventor
Nicholas Bodor
Thorsteinn Loftsson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Key Pharmaceuticals Inc
Original Assignee
Key Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Key Pharmaceuticals Inc filed Critical Key Pharmaceuticals Inc
Application granted granted Critical
Publication of DE3688075D1 publication Critical patent/DE3688075D1/de
Publication of DE3688075T2 publication Critical patent/DE3688075T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
DE8787900446T 1985-12-06 1986-12-05 Transdermales verabreichungssystem. Expired - Fee Related DE3688075T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/806,257 US4764381A (en) 1985-12-06 1985-12-06 Percutaneous penetration enhancer of oleic acid and 2-ethyl-1, 3-hexanediol
PCT/US1986/002584 WO1987003490A2 (en) 1985-12-06 1986-12-05 Transdermal delivery system

Publications (2)

Publication Number Publication Date
DE3688075D1 true DE3688075D1 (de) 1993-04-22
DE3688075T2 DE3688075T2 (de) 1993-06-24

Family

ID=25193671

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8787900446T Expired - Fee Related DE3688075T2 (de) 1985-12-06 1986-12-05 Transdermales verabreichungssystem.

Country Status (11)

Country Link
US (2) US4764381A (de)
EP (2) EP0393727A3 (de)
JP (1) JPS63502108A (de)
KR (1) KR900002653B1 (de)
AT (1) ATE86870T1 (de)
AU (2) AU602324B2 (de)
CA (1) CA1280974C (de)
DE (1) DE3688075T2 (de)
DK (1) DK407587D0 (de)
MY (1) MY102378A (de)
WO (1) WO1987003490A2 (de)

Families Citing this family (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4933184A (en) * 1983-12-22 1990-06-12 American Home Products Corp. (Del) Menthol enhancement of transdermal drug delivery
US4931283A (en) * 1983-12-22 1990-06-05 American Home Products Corp. (Del) Menthol enhancement of transdermal drug delivery
US4983396A (en) * 1985-12-06 1991-01-08 Key Pharmaceuticals, Inc. Percutaneous penetration enhancer of oleic acid and 2-ethyl-1,3-hexanediol
US5045317A (en) * 1987-07-16 1991-09-03 The Regents Of The University Of California Enhancing the cutaneous penetration of pharmacologically active agents
US5051260A (en) * 1987-07-16 1991-09-24 The Regents Of The University Of California Method and composition for enhancing the cutaneous penetration of pharmacologically active agents
US4971800A (en) * 1988-07-08 1990-11-20 The Regents Of The University Of California Method and compositions for enhancing the cutaneous penetration of pharmacologically active agents
US4994267A (en) * 1988-03-04 1991-02-19 Noven Pharmaceuticals, Inc. Transdermal acrylic multipolymer drug delivery system
US5059603A (en) * 1989-06-12 1991-10-22 Centuries Laboratories, Inc. Method and composition for treating impotence
US5262165A (en) * 1992-02-04 1993-11-16 Schering Corporation Transdermal nitroglycerin patch with penetration enhancers
NZ234919A (en) * 1989-08-17 1992-07-28 Schering Corp Polymeric matrix or reservoir transdermal nitroglycerin patch which contains n-methyl-2-pyrrolidone and/or penetration enhancer(s); preparatory processes
AR246186A1 (es) * 1989-11-17 1994-07-29 Beta Pharm Co Procedimiento para fabricar un dispositivo para administrar estradiol por via transdermica.
JP2849950B2 (ja) * 1990-11-30 1999-01-27 日東電工株式会社 経皮吸収製剤
US5202125A (en) * 1990-12-10 1993-04-13 Theratech, Inc. Method and systems for administering nitroglycerin transdermally at enhanced transdermal fluxes
US5518734A (en) * 1991-09-25 1996-05-21 Beta Pharmaceuticals Co. Transdermal delivery system for estradiol and process for manufacturing said device
US5705185A (en) * 1991-09-25 1998-01-06 Beta Pharmaceuticals Co. Transdermal delivery of estradiol and process for manufacturing said device
JP2960832B2 (ja) * 1992-05-08 1999-10-12 ペルマテック テクノロジー アクチェンゲゼルシャフト エストラジオールの投与システム
US5613958A (en) * 1993-05-12 1997-03-25 Pp Holdings Inc. Transdermal delivery systems for the modulated administration of drugs
WO1995006466A1 (en) * 1993-09-01 1995-03-09 Koren Laboratories Pty. Limited Treatment of anorectal disorders
US5552153A (en) * 1994-04-28 1996-09-03 Hoffman-La Roche Inc. Pharmaceutical composition for transdermal delivery
US5580574A (en) * 1994-04-28 1996-12-03 Hoffmann-La Roche Inc. Pharmaceutical composition for transdermal delivery
DE69535607T2 (de) 1994-05-27 2008-07-10 Strakan International Ltd. Zusammensetzung enthaltend Stickstoffoxid-donatoren und Methode zur Behandlung analer Krankheiten
FR2732223B1 (fr) * 1995-03-30 1997-06-13 Sanofi Sa Composition pharmaceutique pour administration transdermique
US5707612A (en) * 1996-04-08 1998-01-13 Alzo, Inc. Use urethane polymers of castor oil skin and personal care product compositiions
DK0957906T3 (da) * 1996-10-14 2002-05-27 Kowa Co Lokalanæstetisk middel til udvortes brug
US20060002949A1 (en) 1996-11-14 2006-01-05 Army Govt. Of The Usa, As Rep. By Secretary Of The Office Of The Command Judge Advocate, Hq Usamrmc. Transcutaneous immunization without heterologous adjuvant
US6797276B1 (en) 1996-11-14 2004-09-28 The United States Of America As Represented By The Secretary Of The Army Use of penetration enhancers and barrier disruption agents to enhance the transcutaneous immune response
US5980898A (en) 1996-11-14 1999-11-09 The United States Of America As Represented By The U.S. Army Medical Research & Material Command Adjuvant for transcutaneous immunization
IT1294748B1 (it) 1997-09-17 1999-04-12 Permatec Tech Ag Formulazione per un dispositivo transdermico
US8980290B2 (en) 2000-08-03 2015-03-17 Antares Pharma Ipl Ag Transdermal compositions for anticholinergic agents
US7198801B2 (en) * 2000-08-03 2007-04-03 Antares Pharma Ipl Ag Formulations for transdermal or transmucosal application
US7214381B2 (en) * 2000-08-03 2007-05-08 Antares Pharma Ipl Ag Composition for transdermal and/or transmucosal administration of active compounds that ensures adequate therapeutic levels
US20040198706A1 (en) * 2003-03-11 2004-10-07 Carrara Dario Norberto R. Methods and formulations for transdermal or transmucosal application of active agents
US20070225379A1 (en) * 2001-08-03 2007-09-27 Carrara Dario Norberto R Transdermal delivery of systemically active central nervous system drugs
ES2310201T3 (es) 2001-02-13 2009-01-01 Government Of The United States Of America, As Represented By The Secretary Of The Army Vacuna para inmunizacion transcutanea contra la diarrea de los viajeros.
US6727287B2 (en) 2001-04-16 2004-04-27 Pts International, Inc. Toluene sulfonamide-containing anti-tumor composition and method of use thereof
DE20107040U1 (de) * 2001-04-24 2002-10-02 Novartis Ag Dosierlanze
AT411327B (de) * 2001-08-23 2003-12-29 Heil Bettina Hormonpräparat mit ungesättigten fettsäuren
WO2005009510A2 (en) * 2003-07-23 2005-02-03 The Regents Of The University Of California Penetration enhancer combinations for transdermal delivery
ATE534373T1 (de) * 2003-10-10 2011-12-15 Antares Pharma Ipl Ag Transdermale pharmazeutische formulierung zur minimierung von rückständen auf der haut
EP1747033A1 (de) 2004-04-30 2007-01-31 Burrell E. Clawson Gerät und verfahren zur isolierung von bereichen eines menschlichen körpers für lokalisierte kühlung
US7425340B2 (en) * 2004-05-07 2008-09-16 Antares Pharma Ipl Ag Permeation enhancing compositions for anticholinergic agents
US20060078580A1 (en) * 2004-10-08 2006-04-13 Mediquest Therapeutics, Inc. Organo-gel formulations for therapeutic applications
US7740875B2 (en) * 2004-10-08 2010-06-22 Mediquest Therapeutics, Inc. Organo-gel formulations for therapeutic applications
WO2007124250A2 (en) 2006-04-21 2007-11-01 Antares Pharma Ipl Ag Methods of treating hot flashes with formulations for transdermal or transmucosal application
WO2006125642A1 (en) 2005-05-27 2006-11-30 Antares Pharma Ipl Ag Methods and apparatus for transdermal or transmucosal application of testosterone
JP5184342B2 (ja) * 2006-03-08 2013-04-17 日本農薬株式会社 外用の医薬組成物
JP5184341B2 (ja) * 2006-03-08 2013-04-17 日本農薬株式会社 外用の医薬組成物
ES2421613T3 (es) * 2006-03-08 2013-09-04 Nihon Nohyaku Co Ltd Composición farmacéutica externa
WO2008067991A2 (en) * 2006-12-08 2008-06-12 Antares Pharma Ipl Ag Skin-friendly drug complexes for transdermal administration
US9283177B2 (en) * 2007-01-16 2016-03-15 Juventio, Llc Topical anesthetic for rapid local anesthesia and method of applying a topical anesthetic
US8759391B2 (en) * 2007-01-16 2014-06-24 Juventio, Llc Topical anesthetic for rapid local anesthesia
HUE030028T2 (en) * 2007-09-05 2017-04-28 Pola Pharma Inc Antifungal drug
EP2191827B1 (de) * 2007-09-05 2013-10-30 Pola Pharma Inc. Antimykotische zusammensetzung
EP2191826B1 (de) * 2007-09-05 2017-03-08 Pola Pharma Inc. Pharmazeutische zusammensetzung
US9050293B2 (en) * 2008-07-16 2015-06-09 Juventio, Llc Small molecule solubilization system
DE102009013469B4 (de) 2009-03-19 2014-04-17 Bubbles And Beyond Gmbh Zubereitung zur äußerlichen Anwendung
US9050271B2 (en) 2009-04-09 2015-06-09 Pola Pharma Inc. Antimycotic pharmaceutical composition
US10130610B2 (en) 2009-04-09 2018-11-20 Pola Pharma Inc. Antimycotic pharmaceutical composition
US8952044B2 (en) 2009-08-25 2015-02-10 Pola Pharma Inc. Antimycotic pharmaceutical composition
ITMI20111284A1 (it) 2011-07-11 2013-01-12 Giovanni Nusca Composizione farmaceutica.
ES2813340T3 (es) 2012-09-21 2021-03-23 Intensity Therapeutics Inc Método de tratamiento del cáncer
CA2942078C (en) 2014-03-14 2023-03-14 The University Of North Carolina At Chapel Hill Small molecules for inhibiting male fertility
JP2022553816A (ja) 2019-11-06 2022-12-26 スマーテック トピカル，インコーポレイテッド シクロオキシゲナーゼ阻害剤の局所配合剤およびその使用

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE243661C (de) *
FR1111910A (fr) * 1953-11-11 1956-03-06 Boehringer Sohn Ingelheim Procédé pour préparer des masses solidifiées et moulables pour des usages cosmétiques et pharmaceutiques
IT1055518B (it) * 1971-05-18 1982-01-11 Rotta Research Lab Derivatives del triptofano
DE2707878C2 (de) * 1977-02-24 1986-01-30 Kali-Chemie Pharma Gmbh, 3000 Hannover Verwendung von Mono- und/oder Diglyceriden mittelkettiger Fettsäuren
FI65914C (fi) * 1978-03-07 1984-08-10 Sandoz Ag Foerfarande foer framstaellning av farmaceutiska kompositionerinnehaollande cyklosporin a
FR2435950A1 (fr) * 1978-06-05 1980-04-11 Riker Laboratories Inc Pansement medical comprenant une composition a base de nitroglycerine, sa fabrication et son application
US4241084A (en) * 1979-08-30 1980-12-23 Minuto Maurice M Antibacterial and antifungal compositions
CA1163561A (en) * 1979-11-06 1984-03-13 Cyril Boroda Preparation containing nitroglycerine and optionally other medicaments and preparation thereof
CA1165240A (en) * 1980-07-09 1984-04-10 The Procter & Gamble Company Penetrating topical pharmaceutical compositions
US4305936A (en) * 1980-10-09 1981-12-15 Dermik Laboratories Topical corticosteroid formulations
US4460372A (en) * 1981-02-17 1984-07-17 Alza Corporation Percutaneous absorption enhancer dispenser for use in coadministering drug and percutaneous absorption enhancer
US4440777A (en) * 1981-07-07 1984-04-03 Merck & Co., Inc. Use of eucalyptol for enhancing skin permeation of bio-affecting agents
US4522872A (en) * 1982-04-12 1985-06-11 Milliken Research Corporation Industrial fabrics
AU569277B2 (en) * 1983-03-03 1988-01-28 Dow Chemical Company, The Aqueuos dispersion of water-insoluble organophilic cellulose ether for sustained release of active agents
DK243084A (da) * 1983-05-26 1984-11-27 Takeda Chemical Industries Ltd Perkutane farmaceutiske praeparater til udvortes brug
US4605548A (en) * 1983-05-31 1986-08-12 Nitto Electric Industrial Co., Ltd. Drug administration material
US4557934A (en) * 1983-06-21 1985-12-10 The Procter & Gamble Company Penetrating topical pharmaceutical compositions containing 1-dodecyl-azacycloheptan-2-one
CA1272445A (en) * 1985-02-25 1990-08-07 Yie W. Chien Transdermal pharmaceutical absorption dosage unit and process of pharmaceutical administration

Also Published As

Publication number Publication date
KR900002653B1 (ko) 1990-04-21
DE3688075T2 (de) 1993-06-24
EP0393727A3 (de) 1990-11-22
CA1280974C (en) 1991-03-05
EP0250542A1 (de) 1988-01-07
AU6115890A (en) 1991-02-07
MY102378A (en) 1992-06-17
AU602324B2 (en) 1990-10-11
DK407587A (da) 1987-08-05
KR880700675A (ko) 1988-04-11
EP0393727A2 (de) 1990-10-24
AU625830B2 (en) 1992-07-16
DK407587D0 (da) 1987-08-05
ATE86870T1 (de) 1993-04-15
JPS63502108A (ja) 1988-08-18
EP0250542B1 (de) 1993-03-17
AU6733687A (en) 1987-06-30
WO1987003490A3 (en) 1987-07-30
US4885174A (en) 1989-12-05
WO1987003490A2 (en) 1987-06-18
US4764381A (en) 1988-08-16

Similar Documents

Publication Publication Date Title
DE3688075D1 (de) Transdermales verabreichungssystem.
ATE72991T1 (de) Nasale verabreichung von arzneimitteln.
EP0435436A3 (en) Transdermal flux enhancers in combination with iontophoresis in topical administration of pharmaceuticals
ES2013129A6 (es) Procedimiento de obtencion de una composicion farmaceutica a base de n-metil-n- (1-fenil -2- propil) -2- propinilamina.
IT1197038B (it) Composizione farmaceutica ad attivita' analgesica
DE3751761T2 (de) Penetrationsverbesserer für die transdermale Verabreichung von systemisch wirksamen Arzneimitteln
DE3884517D1 (de) Biologisch aktive carbonsaeureester.
DE3769707D1 (de) Therapeutisches system mit geregelter wirkstoffabgabe.
IT8520973A0 (it) Benzoil-uree ad attivita'insetticida.
TR23901A (tr) Insektisid özellikte n-sübstitüe n,n'-diacilhidrazinler
IT8622554A0 (it) Dispositivo di supporto particolarmente per tralci di vite, rami di alberi e simili.
IT8721063A0 (it) Composizione ad attivita'tricogena.
IT1169873B (it) Composizione farmaceutica ad attivita' sistemica anticolinesterasica, agonista-colinergica ed antimuscarinica
IT8519915A0 (it) Benzoil-uree ad attivita'insetticida.
DE3867086D1 (de) Benzothiepino(5,4-c)pyridazin-verbindungen und ihre pharmazeutischen wirkungen.
DE3877630T2 (de) Transkutane verabreichung von pharmazeutika.
ES2037691T3 (es) Colirio liquido preparado con un contenido de acido cromoglicinico.
FI862493A (fi) Fysiologiska medel foer effektivering av transdermal administration av laekemedel.
FR2595481B3 (fr) Pendule, notamment pendule 400 jours a balancier tournant
ES2051788T3 (es) Un producto farmaceutico.
SU1744810A1 (ru) Вазоактивное средство, нормализующее функции вегетативной нервной системы "димефосфон"
NO873145D0 (no) Transdermal avlevering av legemidler.
IT8620847A0 (it) Composti ad attivita'anti-ipertenisiva.
RO91712B1 (ro) Solutie injectabila cu actiune coronarodilatoare si antihipertensiva
IT1222074B (it) Composizione ad attivita' antiforfora

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee